Jill A. Fisher and Maral Erol are co-authors, with colleague Edwin H. Kim, on a new article in Annals of Allergy, Asthma & Immunology.
The researchers interviewed providers in community practice or academic medical centers. They asked providers about “their perceptions of the risks and benefits of current and future FA treatment options,” with a focus on biologics.
While most respondents were “enthusiastic,” there were mixed views from the interviews. Some concerns included patient costs and healthcare system costs.
“Community and Academic Allergists’ Perspectives on Integrating Biologics into Food Allergy Care: A Qualitative Study” is available now as an article in press.